Related Experiment Video
Updated: May 28, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
Regulation of MDM2 E3 ligase activity by phosphorylation after DNA damage
Qian Cheng1, Brittany Cross, Baozong Li
1Molecular Oncology Department, Moffitt Cancer Center, Tampa, Florida 33612, USA.
Abstract:
MDM2 is a major regulator of p53 by acting as a ubiquitin E3 ligase. The central acidic domain and C-terminal RING domain of MDM2 are both indispensable for ubiquitination of p53. Our previous study suggested that ATM phosphorylation of MDM2 near the C terminus inhibits RING domain oligomerization, resulting in p53 stabilization after DNA damage. We present here evidence that these modifications allosterically regulate the functions of both acidic domain and RING domain of MDM2. Using chemical cross-linking, we show that the MDM2 RING domain forms oligomers including dimer and higher-order complexes in vivo. RING domain dimerization efficiency is negatively regulated by upstream sequence. ATM-mediated phosphorylation of the upstream sequence further inhibits RING dimerization. Forced oligomerization of MDM2 partially overcomes the inhibitory effect of phosphorylation and stimulates p53 ubiquitination. Furthermore, the ability of MDM2 acidic domain to bind p53 core domain and induce p53 misfolding are also suppressed by the same C-terminal ATM sites after DNA damage. These results suggest that the acidic domain and RING domain of MDM2 are both allosterically coupled to the intervening ATM sites, which enables the same modification to regulate multiple MDM2 functions critical for p53 ubiquitination.
Insights
MDM2
Area of Science:
- Molecular Biology
- Cellular Regulation
- Cancer Research
Background:
- MDM2 (mouse double minute 2 homolog) is a key E3 ubiquitin ligase regulating the tumor suppressor p53.
- Both the acidic domain and RING domain of MDM2 are essential for p53 ubiquitination.
- Previous work indicated ATM phosphorylation inhibits MDM2 RING domain oligomerization, stabilizing p53 post-DNA damage.
Purpose of the Study:
- To investigate how ATM phosphorylation allosterically regulates MDM2's acidic and RING domains.
- To elucidate the role of MDM2 RING domain oligomerization in p53 ubiquitination.
- To understand how C-terminal ATM phosphorylation impacts MDM2's interaction with p53.
Main Methods:
- Chemical cross-linking to assess MDM2 RING domain oligomerization in vivo.
- Analysis of upstream sequence regulation on RING domain dimerization.
- Investigating the effect of ATM-mediated phosphorylation on MDM2 function.
- Assessing the impact of forced MDM2 oligomerization on p53 ubiquitination.
- Evaluating MDM2 acidic domain binding to p53 core domain and p53 misfolding.
Main Results:
- MDM2's RING domain forms dimers and higher-order oligomers in vivo.
- RING domain dimerization is negatively regulated by an upstream sequence.
- ATM phosphorylation of this upstream sequence further inhibits RING dimerization.
- Forced MDM2 oligomerization partially reverses phosphorylation's inhibitory effects and enhances p53 ubiquitination.
- ATM phosphorylation at C-terminal sites suppresses MDM2's acidic domain binding to p53 and p53 misfolding.
Conclusions:
- MDM2's acidic and RING domains are allosterically linked to ATM phosphorylation sites.
- A single C-terminal ATM modification regulates multiple MDM2 functions crucial for p53 ubiquitination.
- This allosteric regulation provides a mechanism for coordinating p53 ubiquitination after DNA damage.
More Related Videos
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

